Institute of Health and Society, University of Oslo, Norway.
Soc Sci Med. 2022 Jan;292:114624. doi: 10.1016/j.socscimed.2021.114624. Epub 2021 Dec 2.
In this reply to Ashraf et al.'s (2021) commentary, I defend my argument that the randomised control trial (RCT) conducted by Ashraf et al. has caused harm in Zambia. I engage with the central points made by Ashraf et al. (2021), but also discuss a broader issue that they chose not to address in their commentary: the politics and ethics of conducting RCTs in countries in the Global South and the political vision of economists who regard RCTs as a solution to poverty and global health problems.
在对 Ashraf 等人(2021)的评论的回复中,我为自己的观点辩护,即 Ashraf 等人进行的随机对照试验(RCT)在赞比亚造成了伤害。我与 Ashraf 等人(2021)提出的要点进行了互动,但也讨论了他们在评论中选择不涉及的更广泛的问题:在全球南方国家进行 RCT 的政治和伦理问题,以及将 RCT 视为解决贫困和全球健康问题的一种方法的经济学家的政治愿景。